Brandywine Oak Private Wealth LLC Reduces Position in CME Group Inc. $CME

Brandywine Oak Private Wealth LLC cut its position in CME Group Inc. (NASDAQ:CME) by 1.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,052 shares of the financial services provider’s stock after selling 50 shares during the period. Brandywine Oak Private Wealth LLC’s holdings in CME Group were worth $841,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of CME. Wayfinding Financial LLC purchased a new position in shares of CME Group in the 1st quarter valued at $25,000. Webster Bank N. A. grew its position in shares of CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares during the last quarter. Cornerstone Planning Group LLC grew its position in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after buying an additional 55 shares during the last quarter. Highline Wealth Partners LLC grew its position in shares of CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC grew its position in shares of CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after buying an additional 98 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Up 1.5%

Shares of NASDAQ:CME opened at $268.84 on Friday. The stock has a market cap of $96.88 billion, a P/E ratio of 26.03, a P/E/G ratio of 5.58 and a beta of 0.41. The firm has a fifty day moving average price of $269.07 and a 200 day moving average price of $271.10. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter last year, the business earned $2.56 EPS. The business’s revenue was up 10.4% on a year-over-year basis. Sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is 48.40%.

Insider Activity

In other news, Director William R. Shepard bought 262 shares of CME Group stock in a transaction dated Thursday, September 25th. The stock was bought at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the purchase, the director owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company’s stock, valued at $4,734,436.80. This trade represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock worth $3,527,956 over the last quarter. Insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and increased their target price for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. UBS Group dropped their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research report on Monday, September 8th. Oppenheimer increased their target price on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Finally, Piper Sandler increased their target price on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $279.23.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.